日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

PIP5K1A Suppresses Ferroptosis and Induces Sorafenib Resistance by Stabilizing NRF2 in Hepatocellular Carcinoma.

PIP5K1A 通过稳定肝细胞癌中的 NRF2 抑制铁死亡并诱导索拉非尼耐药性

Guo Mengzhou, Chen Sinuo, Sun Jialei, Xu Ruchen, Qi Zhuoran, Li Jie, Zhou Lianer, Fang Yuan, Liu Tianshu, Xia Jinglin

YAP-activated NAT10 promotes hepatoblastoma progression by activating the pentose phosphate pathway

YAP激活的NAT10通过激活磷酸戊糖途径促进肝母细胞瘤进展。

Wang, Lingxiao; Yang, Shiguang; Li, Jie; Fang, Yuan; Guo, Mengzhou; Du, Xiaojing; Song, Li; Chen, Sinuo; Zhang, Xingxing; Qi, Zhuoran; Zhang, Kaihui; Lv, Bei; Xia, Jinglin

Chinese Expert Consensus on the Whole-Course Management of Hepatocellular Carcinoma (2023 Edition)

中国肝细胞癌全程管理专家共识(2023版)

Yang, Yu; Sun, Juxian; Cai, Jianqiang; Chen, Minshan; Dai, Chaoliu; Wen, Tianfu; Xia, Jinglin; Ying, Mingang; Zhang, Zhiwei; Zhang, Xuewen; Fang, Chihua; Shen, Feng; An, Ping; Cai, Qingxian; Cao, Jingyu; Zeng, Zhen; Chen, Gang; Chen, Juan; Chen, Ping; Chen, Yongshun; Shan, Yunfeng; Dang, Shuangsuo; Guo, Wei-Xing; He, Jiefeng; Hu, Heping; Huang, Bin; Jia, Weidong; Jiang, Kexiang; Jin, Yan; Jin, Yongdong; Jin, Yun; Li, Gong; Liang, Yun; Liu, Enyu; Liu, Hao; Peng, Wei; Peng, Zhenwei; Peng, Zhiyi; Qian, Yeben; Ren, Wanhua; Shi, Jie; Song, Yusheng; Tao, Min; Tie, Jun; Wan, Xueying; Wang, Bin; Wang, Jin; Wang, Kai; Wang, Kang; Wang, Xin; Wei, Wenjing; Wu, Fei-Xiang; Xiang, Bangde; Xie, Lin; Xu, Jianming; Yan, Mao-Lin; Ye, Yufu; Yue, Jinbo; Zhang, Xiaoxun; Zhang, Yu; Zhang, Aibin; Zhao, Haitao; Zhao, Weifeng; Zheng, Xin; Zhou, Hongkun; Zhou, Huabang; Zhou, Jun; Zhou, Xinmin; Cheng, Shu-Qun; Li, Qiu

Survival in patients with unresectable hepatocellular carcinoma: TCC cocktail plus TACE vs TACE alone prospective randomized clinical trial

不可切除肝细胞癌患者的生存率:TCC鸡尾酒疗法联合TACE与单独TACE的前瞻性随机临床试验

Li, Jie; Lv, Bei; Song, Li; Zhang, Xingxing; Zhang, Jian; Ding, Xiaoyi; Liu, Yongqiang; Ye, Tao; Guo, Mengzhou; Fang, Tingting; Yang, Biwei; Zhao, Zhiying; Huang, Peixin; Chen, Yi; Ge, Ningling; Xia, Jinglin

MRI Radiomics to Predict Early Treatment Response to TACE Combined with Lenvatinib Plus a PD-1 Inhibitor for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus

MRI放射组学预测肝细胞癌门静脉癌栓患者接受TACE联合乐伐替尼加PD-1抑制剂治疗的早期疗效

Lu, Deyu; Zhou, Lingling; Zuo, Ziyi; Zhang, Zhao; Zheng, Xiangwu; Weng, Jialu; Yu, Zhijie; Ji, Jiansong; Xia, Jinglin

Explainable machine learning model for predicting the transarterial chemoembolization response and subtypes of hepatocellular carcinoma patients

用于预测肝细胞癌患者经动脉化疗栓塞治疗反应和亚型的可解释机器学习模型

Zhang, Yunjie; Tong, Songjian; Yang, Junhui; Lin, Jiawei; Kong, Yifan; Lu, Deyu; Chen, Yan; Li, Yingchao; Xu, Linfeng; Kong, Xiuyan; Zhu, Guoqing; Zhang, Hao; Liu, Pixu; Yu, Zhijie; Xia, Jinglin

Gelation embolism agents suppress clinical TACE-incited pro-metastatic microenvironment against hepatocellular carcinoma progression

凝胶栓塞剂可抑制临床TACE诱导的促转移微环境,从而抑制肝细胞癌的进展。

Song, Li; Zhu, Chunyan; Shi, Qing; Xia, Yuhan; Liang, Xiayi; Qin, Wen; Ye, Tao; Yang, Biwei; Cao, Xin; Xia, Jinglin; Zhang, Kun

Corrigendum to "Emulsifying Lipiodol with pH-Sensitive DOX@HmA nanoparticles for hepatocellular carcinoma TACE treatment eliminate metastasis" Mater. Today Bio, 23, 2023, 100873, ISSN 2590-0064

关于“乳化碘油与pH敏感型DOX@HmA纳米颗粒用于肝细胞癌TACE治疗可消除转移”一文的更正,Mater. Today Bio, 23, 2023, 100873, ISSN 2590-0064

Shi, Qing; Zhang, Xingxing; Wu, Minmin; Xia, Yuhan; Pan, Yating; Weng, Jialu; Li, Na; Zan, Xingjie; Xia, Jinglin

Synergistic immunochemotherapy targeted SAMD4B-APOA2-PD-L1 axis potentiates antitumor immunity in hepatocellular carcinoma

协同免疫化疗靶向SAMD4B-APOA2-PD-L1轴可增强肝细胞癌的抗肿瘤免疫力

Qi, Feng; Zhang, Jian; Li, Jia; Li, Donghe; Gao, Na; Qi, Zhuoran; Kong, Xiuyan; Yu, Zhijie; Fang, Yuan; Cui, Wenguo; Xia, Jinglin

Author Correction: Synergistic immunochemotherapy targeted SAMD4B-APOA2-PD-L1 axis potentiates antitumor immunity in hepatocellular carcinoma

作者更正:协同免疫化疗靶向SAMD4B-APOA2-PD-L1轴可增强肝细胞癌的抗肿瘤免疫力

Qi, Feng; Zhang, Jian; Li, Jia; Li, Donghe; Gao, Na; Qi, Zhuoran; Kong, Xiuyan; Yu, Zhijie; Fang, Yuan; Cui, Wenguo; Xia, Jinglin